About Progenity
Progenity is a company based in San Diego (United States) founded in 2011 by Harry Stylli.. Progenity has raised $216.63 million across 9 funding rounds from investors including Athyrium Capital Management. The company has 125 employees as of December 31, 2022. Progenity has completed 1 acquisition, including Carmenta Bio. Progenity offers products and services including BioJet and NaviCap. Progenity operates in a competitive market with competitors including Natera, BillionToOne, SYNLAB, Beikang Medical and Yourgene Health, among others.
- Headquarter San Diego, United States
- Employees 125 as on 31 Dec, 2022
- Founders Harry Stylli
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biora Therapeutics, Inc.
-
Annual Revenue
$1.25 M670as on Dec 31, 2021
-
Net Profit
-
EBITDA
-
Total Equity Funding
$216.63 M (USD)
in 9 rounds
-
Latest Funding Round
$40 M (USD), Post-IPO
May 11, 2021
- Investors
-
Employee Count
125
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Progenity
Progenity offers a comprehensive portfolio of products and services, including BioJet and NaviCap. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides needle-free oral delivery of large molecules for chronic diseases.
Enables targeted oral delivery of therapeutics in specific body areas.
Unlock access to complete
Unlock access to complete
Funding Insights of Progenity
Progenity has successfully raised a total of $216.63M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $40 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $40.0M
-
First Round
First Round
(12 Jun 2013)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2021 | Amount | Post-IPO - Progenity | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Progenity | Valuation |
investors |
|
| Dec, 2020 | Amount | Post-IPO - Progenity | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Progenity
Progenity has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Athyrium Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed by the firm.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Progenity
Progenity has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Carmenta Bio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostics for women's health
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Progenity
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Progenity Comparisons
Competitors of Progenity
Progenity operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, BillionToOne, SYNLAB, Beikang Medical and Yourgene Health, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of cell-free cancer liquid biopsy test
|
|
| domain | founded_year | HQ Location |
Provider of medical diagnosis and clinical laboratory analysis services
|
|
| domain | founded_year | HQ Location |
NGS-based diagnostic solutions for neonatal screening are developed.
|
|
| domain | founded_year | HQ Location |
Non-invasive prenatal genetic tests and genomic services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Progenity
Frequently Asked Questions about Progenity
When was Progenity founded?
Progenity was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Where is Progenity located?
Progenity is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Progenity?
Harry Stylli is the current CEO of Progenity. They have also founded this company.
Is Progenity a funded company?
Progenity is a funded company, having raised a total of $216.63M across 9 funding rounds to date. The company's 1st funding round was a Post-IPO of $75M, raised on Jun 12, 2013.
How many employees does Progenity have?
As of Dec 31, 2022, the latest employee count at Progenity is 125.
What is the annual revenue of Progenity?
Annual revenue of Progenity is $1.25M as on Dec 31, 2021.
What does Progenity do?
Provider of non-invasive prenatal genomic testing. The companys diagnostic platform is based on genomics, epigenomics, proteomics, and metabolomics. The companys products include a Preparent carrier test for prenatal genetic disorders, an Innatal prenatal screen for chromosomal-related disorders, hereditary cancer risk prediction, and Resura prenatal test for detecting monogenic disorders. The company also developing precision medicine for prenatal, perinatal, oncology, and gastroenterology diseases.
Who are the top competitors of Progenity?
Progenity's top competitors include Natera, BillionToOne and Pictor.
What products or services does Progenity offer?
Progenity offers BioJet and NaviCap.
How many acquisitions has Progenity made?
Progenity has made 1 acquisition, including Carmenta Bio.
Who are Progenity's investors?
Progenity has 1 investor. Key investors include Athyrium Capital Management.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.